Socioeconomic status and use of obesogenic and anti- obesity medications in the United States: A population-based study

被引:0
|
作者
Lyu, Beini [1 ]
Chang, Alex R. [2 ]
Inker, Lesley A. [3 ]
Selvin, Elizabeth [1 ,4 ]
Grams, Morgan E. [1 ,4 ,5 ,6 ]
Shin, Jung-Im [1 ,5 ,6 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 2024 E Monument St, Suite 2-600,room 2-204, Baltimore, MD 21205 USA
[2] Geisinger Hlth Syst, Kidney Hlth Res Inst, Danville, PA USA
[3] Tufts Med Ctr, Div Nephrol, Boston, MA USA
[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD USA
[5] Johns Hopkins Univ, Ctr Drug Safety & Effectiveness, Baltimore, MD USA
[6] Johns Hopkins Univ, Welch Ctr Prevent, Epidemiol & Clin Res, Baltimore, MD USA
来源
LANCET REGIONAL HEALTH-AMERICAS | 2022年 / 11卷
关键词
Obesity; Obesogenic medications; Socioeconomic status; Disparities; Pharmacoequity;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background The Endocrine Society Clinical Practice Guidelines recommend the avoidance of medications that may cause weight gain (i.e., obesogenic medications) in individuals with overweight or obesity. Obesity disproportion-ately affects people with lower socioeconomic status (SES); however, it is unknown whether the use of obesogenic medications differs by SES.Methods We included adults with overweight or obesity and used prescription medications from 2009-2018 of the US National Health and Nutrition Examination Survey. We examined the associations between a composite measure of SES and use of obesogenic medications and anti-obesity medications. The composite SES included 1 point), household income below federal poverty level (1 point), no insurance (2 points), and public health insurance only (1 point). We defined 3 composite SES groups (0 [high], 1 [intermediate], and >= 2 points [low]).Findings Among 10,673 US adults with overweight or obesity, 20.0% had low SES. Use of obesogenic medications was common (37.7%). Low (vs. high) SES was associated with greater obesogenic medication use, independent of demographic characteristics, prescription medication burden, and comorbidities (OR 1.3 [1.2-1.5]). Among 12,133 eli-gible participants, utilization of anti-obesity medications was very low overall (0.5%) and within all SES groups (low 0.27%, intermediate 0.71, and high 0.65%).Interpretation Our findings highlight common and modifiable risk factors for obesity. Clinicians should screen patient medications for those that may cause weight gain and increase adoption of anti-obesity medications, espe-cially among adults living in low SES. Funding The National Institute of Diabetes and Digestive and Kidney Disease (R01DK115534, K24HL155861, and K01DK121825). Copyright (c) 2022 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Unstaged cancer in the United States: a population-based study
    Merrill, Ray M.
    Sloan, Arielle
    Anderson, Allison E.
    Ryker, Karem
    BMC CANCER, 2011, 11
  • [32] Trends of chronic liver diseases by income level and socioeconomic factors in the United States: A population-based study
    Lee, Eunice Yewon
    Nguyen, Vy H.
    Cheung, Ramsey
    Nguyen, Mindie H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (10) : 1374 - 1387
  • [33] Incidence of melanoma and its subtypes by neighborhood-level socioeconomic status: A United States population-based cohort analysis
    Hoang, M.
    Mirza, F. N.
    Weinstock, M. A.
    Qureshi, A. A.
    Cho, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : S91 - S91
  • [34] A population-based study of dosing and persistence with anti-dementia medications
    Linda Brewer
    Kathleen Bennett
    Cora McGreevy
    David Williams
    European Journal of Clinical Pharmacology, 2013, 69 : 1467 - 1475
  • [35] Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis
    Filion, Kristian B.
    Joseph, Lawrence
    Boivin, Jean-Francois
    Suissa, Samy
    Brophy, James M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (10) : 973 - 976
  • [36] A population-based study of dosing and persistence with anti-dementia medications
    Brewer, Linda
    Bennett, Kathleen
    McGreevy, Cora
    Williams, David
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (07) : 1467 - 1475
  • [37] Smoking, alcohol, diabetes, obesity, socioeconomic status, and the risk of colorectal cancer in a population-based case–control study
    Terry Boyle
    Lin Fritschi
    Seyed Mehdi Tabatabaei
    Kathrin Ringwald
    Jane S. Heyworth
    Cancer Causes & Control, 2014, 25 : 1659 - 1668
  • [38] Association Between Marijuana Use and Sexual Frequency in the United States: A Population-Based Study
    Sun, Andrew J.
    Eisenberg, Michael L.
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (11): : 1342 - 1347
  • [39] Time of Pregnancy Recognition and Prenatal Care Use: A Population-based Study in the United States
    Ayoola, Adejoke B.
    Nettleman, Mary D.
    Stommel, Manfred
    Canady, Renee B.
    BIRTH-ISSUES IN PERINATAL CARE, 2010, 37 (01): : 37 - 43
  • [40] Dietary Supplements Use among Adults with Cancer in the United States: A Population-Based Study
    Abdel-Rahman, Omar
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2021, 73 (10): : 1856 - 1863